An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of UIC201603 and UIC201604 in Healthy Volunteers
Latest Information Update: 30 Aug 2024
At a glance
- Drugs UI 022 (Primary)
- Indications Peripheral arterial disorders
- Focus Pharmacokinetics
- Sponsors Korea United Pharm Inc
Most Recent Events
- 30 Aug 2024 New trial record